Carboplatin plus paclitaxel scheduling for advanced ovarian cancer

Lancet Oncol. 2014 Jun;15(7):e249-50. doi: 10.1016/S1470-2045(14)70214-1.

Authors

Tomoya Shimokata¹, Yuichi Ando²

Affiliations

¹ Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Electronic address: tshimo@med.nagoya-u.ac.jp.
² Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

PMID: 24872105
DOI: 10.1016/S1470-2045(14)70214-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Ovarian Neoplasms / drug therapy*